Zobrazeno 1 - 10
of 39
pro vyhledávání: '"Isabel González-Mariscal"'
Autor:
Kanikkai Raja Aseer, Caio Henrique Mazucanti, Jennifer F. O’Connell, Isabel González-Mariscal, Anjali Verma, Qin Yao, Christopher Dunn, Qing-Rong Liu, Josephine M. Egan, Máire E. Doyle
Publikováno v:
Molecular Metabolism, Vol 82, Iss , Pp 101917- (2024)
Externí odkaz:
https://doaj.org/article/fc2998fbbee947e0b1e63770929e59bb
Autor:
Kanikkai Raja Aseer, Caio Henrique Mazucanti, Jennifer F. O’Connell, Isabel González-Mariscal, Anjali Verma, Qin Yao, Christopher Dunn, Qing-Rong Liu, Josephine M. Egan, Máire E. Doyle
Publikováno v:
Molecular Metabolism, Vol 82, Iss , Pp 101906- (2024)
Objective: Type 1 diabetes (T1D) occurs because of islet infiltration by autoreactive immune cells leading to destruction of beta cells and it is becoming evident that beta cell dysfunction partakes in this process. We previously reported that geneti
Externí odkaz:
https://doaj.org/article/f9b137e5ebbd4b2fba8b127ac6e303d3
Autor:
Said Lhamyani, Adriana-Mariel Gentile, María Mengual-Mesa, Elia Grueso, Rosa M. Giráldez-Pérez, José Carlos Fernandez-Garcia, Antonio Vega-Rioja, Mercedes Clemente-Postigo, John R. Pearson, Isabel González-Mariscal, Gabriel Olveira, Francisco-Javier Bermudez-Silva, Rajaa El Bekay
Publikováno v:
Biomedicine & Pharmacotherapy, Vol 171, Iss , Pp 116104- (2024)
Despite the abundance of registered clinical trials worldwide, the availability of effective drugs for obesity treatment is limited due to their associated side effects. Thus, there is growing interest in therapies that stimulate energy expenditure i
Externí odkaz:
https://doaj.org/article/4a4f11b5e3e54f26946a4e53a2a0d5e7
Autor:
Isabel González-Mariscal, Macarena Pozo-Morales, Silvana Y. Romero-Zerbo, Vanesa Espinosa-Jimenez, Alejandro Escamilla-Sánchez, Lourdes Sánchez-Salido, Nadia Cobo-Vuilleumier, Benoit R. Gauthier, Francisco J. Bermúdez-Silva
Publikováno v:
Biomedicine & Pharmacotherapy, Vol 145, Iss , Pp 112361- (2022)
The atypical cannabinoid Abn-CBD improves the inflammatory status in preclinical models of several pathologies, including autoimmune diseases. However, its potential for modulating inflammation in autoimmune type 1 diabetes (T1D) is unknown. Herein w
Externí odkaz:
https://doaj.org/article/9083b5b0962f47678e25562542aafcf0
Publikováno v:
Nutrition & Metabolism, Vol 16, Iss 1, Pp 1-11 (2019)
Abstract Background Although type 2 diabetes mellitus (T2DM) is primarily characterized by sustained high levels of circulating glucose, other factors, such as obesity, chronic inflammation, fatty liver, and islet dysfunction significantly contribute
Externí odkaz:
https://doaj.org/article/435cd482ff914ee38c0f7a1f1c6ad827
Autor:
Silvana Y. Romero-Zerbo, María García-Fernández, Vanesa Espinosa-Jiménez, Macarena Pozo-Morales, Alejandro Escamilla-Sánchez, Lourdes Sánchez-Salido, Estrella Lara, Nadia Cobo-Vuilleumier, Alex Rafacho, Gabriel Olveira, Gemma Rojo-Martínez, Benoit R. Gauthier, Isabel González-Mariscal, Francisco J. Bermúdez-Silva
Publikováno v:
Frontiers in Endocrinology, Vol 11 (2020)
Background and Aims: The synthetic atypical cannabinoid Abn-CBD, a cannabidiol (CBD) derivative, has been recently shown to modulate the immune system in different organs, but its impact in obesity-related meta-inflammation remains unstudied. We inve
Externí odkaz:
https://doaj.org/article/2e3857d829864ea1b67a62e47e1c6461
Publikováno v:
Pharmaceuticals, Vol 14, Iss 9, p 863 (2021)
Anti-inflammatory and antidiabetogenic properties have been ascribed to cannabidiol (CBD). CBD-based medicinal drugs have been approved for over a lustrum, and a boom in the commercialization of CBD products started in parallel. Herein, we explored t
Externí odkaz:
https://doaj.org/article/367930f58d464d869c1c815267217785
Autor:
María Soledad Ruiz de Adana, Marta Elena Domínguez, Virginia Morillas, Natalia Colomo, Rosario Vallejo-Mora, Mercedes Guerrero, Eva García-Escobar, Mónica Carreira, Yanina Romero-Zerbo, Francisca Linares, Isabel González-Mariscal, Francisco Javier Bermúdez-Silva, Gabriel Olveira, Gemma Rojo-Martínez
Publikováno v:
Diabetes research and clinical practice.
To compare efficacy and safety of degludec 100 IU/mL (Deg-100) and glargine 300 IU/mL (Gla-300) in adults with type 1 diabetes.Open-label, single-center, randomized, parallel-group, 24-week trial in adults with type 1 diabetes, on basal-bolus insulin
Publikováno v:
Pharmaceuticals, Vol 14, Iss 863, p 863 (2021)
Pharmaceuticals 14(9), 863 (2021)
Pharmaceuticals
Volume 14
Issue 9
Helvia. Repositorio Institucional de la Universidad de Córdoba
instname
Pharmaceuticals 14(9), 863 (2021)
Pharmaceuticals
Volume 14
Issue 9
Helvia. Repositorio Institucional de la Universidad de Córdoba
instname
Anti-inflammatory and antidiabetogenic properties have been ascribed to cannabidiol (CBD). CBD-based medicinal drugs have been approved for over a lustrum, and a boom in the commercialization of CBD products started in parallel. Herein, we explored t
Autor:
Josephine M. Egan, Ruin Moaddel, Yoo Kim, Olga D. Carlson, Paritosh Ghosh, Soumita Ghosh, Jennifer F. O’Connell, Isabel González-Mariscal
Publikováno v:
Obesity Science & Practice, Vol 5, Iss 4, Pp 383-394 (2019)
Obesity Science & Practice
Obesity Science & Practice
Summary Aim Linoleic acid (LA) is an essential fatty acid involved in the biosynthesis of arachidonic acid and prostaglandins. LA is known to induce obesity and insulin resistance. In this study, two concentrations of LA with or without added glucose